News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TechniScan Medical Systems Elects Joe Pepper, Ph.D. as Chairman of the Board


12/15/2010 11:47:17 AM

SALT LAKE CITY, Dec. 15, 2010 /PRNewswire-FirstCall/ -- TechniScan (OTC Bulletin Board: TSNI), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, announced that Joe Pepper, Ph.D. has been elected as chairman of the board of directors of TechniScan.

"As a member of the current board of directors, Joe Pepper has already made significant contributions in helping us bring TechniScan's Warm Bath Ultrasound closer to commercialization, and his leadership and experience in the field will further benefit the company as he takes over as the chairman," said outgoing Board Chairman Ken Hungerford.

Hungerford has served as chairman since the company went public in the fall of 2009, and he will continue to serve on the board's executive committee along with Pepper and TechniScan CEO David Robinson.

With 28 years in the medical device field, Pepper currently serves as a consultant to medical device start-ups. Formerly he served as CEO of U-Systems, Inc., a privately-backed start-up that developed automated ultrasound for the early detection of breast cancer in women with dense breast tissue. He was CEO for OEC Medical Systems, a NYSE-traded, mobile fluoroscopic imaging equipment manufacturer until it was sold to GE Healthcare. He spent 15 years with The BOC Group, Plc., where he served as president of its subsidiary Ohmeda Medical Devices, which was responsible for international selling and distribution of medical devices, and as president of Ohmeda Medical Equipment.

About TechniScan

TechniScan, Inc. is a medical device company engaged in the development and commercialization of a non-invasive imaging tool designed to provide physicians with automated ultrasound images of the human breast. TechniScan's Warm Bath Ultrasound (WBU) imaging device is limited by U.S. law to investigational use unless, and until, cleared by the FDA. For more information, please visit www.tsni.com.

Forward Looking Statements

The company's future operating results are dependent upon many factors, including risk factors discussed in the company's periodic filings with the Securities and Exchange Commission, which are available for review at www.sec.gov, including the company's Annual Report on Form 10-K filed on March 22, 2010.

Contact:

Tracy Harden

435-640-1065

tharden@techniscanmedical.com



SOURCE TechniScan, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES